Proof concept for clinical justification of network mapping for personalized cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proof concept for clinical justification of network mapping for personalized cancer therapeutics

Published:2007-06-01 Issue:8 Volume:14 Page:686-695
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Nemunaitis J,Senzer N,Khalil I,Shen Y,Kumar P,Tong A,Kuhn J,Lamont J,Nemunaitis M,Rao D,Zhang Y-A,Zhou Y,Vorhies J,Maples P,Hill C,Shanahan D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7701057.pdf

Reference79 articles.

1. Berman J . Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches. BMC Cancer 2005; 5: 100.

2. Keith CT, Borisy AA, Stockwell BR . Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 2005; 4: 71–78.

3. Kamb A . What's wrong with our cancer models? Nat Rev Drug Discov 2005; 4: 161–165.

4. Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57–70.

5. Carlson JM, Doyle J . Complexity and robustness. Proc Natl Acad Sci USA 2002; 99 (Suppl 1): 2538–2545.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbonate Apatite and Hydroxyapatite Formulated with Minimal Ingredients to Deliver SiRNA into Breast Cancer Cells In Vitro and In Vivo;Journal of Functional Biomaterials;2020-09-10

2. Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery;Toxicological Sciences;2016-11-04

3. Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer;Molecular Therapy;2015-06

4. Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer;Expert Opinion on Therapeutic Targets;2012-06-12

5. Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue Samples;Biopreservation and Biobanking;2011-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3